Dyfyniad APA

Hurvitz, S. A., Gonçalves, A., Rugo, H. S., Lee, K., Fehrenbacher, L., Mina, L. A., . . . Ettl, J. (2019). Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial. Oncologist.

Dyfyniad Arddull Chicago

Hurvitz, Sara A., et al. "Talazoparib in Patients With a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses From the Phase III EMBRACA Trial." Oncologist 2019.

Dyfyniad MLA

Hurvitz, Sara A., et al. "Talazoparib in Patients With a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses From the Phase III EMBRACA Trial." Oncologist 2019.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.